EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Institut Georges Lopez-2M as a Novel Lung Preservation Solution Attenuates Ischemia-Reperfusion Injury in a Rat Ex Vivo Lung Perfusion Model

Annalisa Barbarossa, Jan Van Slambrouck, Cara Trivett, Phéline Kortleven, Cedric Vanluyten, Alberto Martin Medina, Xin Jin, Nicole Jannis, Balin Özsoy, Sandra Claes, Dominique Schols, Tine Wylin und 9 weitere

Transplant International · 2026

DOI: 10.3389/ti.2026.15993 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Transplant International, 2026. Verfasst von Annalisa Barbarossa und 20 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory for Respiratory Diseases and Thoracic Surgery, Katholieke Universiteit Leuven, Leuven, Belgium. Hauptthemen laut MEDLINE: Organ Preservation Solutions, Reperfusion Injury, Lung, Organ Preservation. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Institut Georges Lopez-2M ( IGL-2M ), a novel preservation solution containing polyethylene glycol (PEG 35kD, 5 g/L), preserves mitochondrial integrity and redox balance in liver grafts. This study assesses IGL-2M ’s effect on lung preservation during prolonged cold ischemia. Rat’s heart-lung blocks were procured and subjected to 18 h cold ischemia (4 °C). Lungs were flushed and preserved using one of these preservation solutions: OCS , Perfadex Plus , IGL-2M (n = 6/group). Following ischemia, lungs underwent up to 7 h normothermic ex vivo lung perfusion. Edema was quantified by weight gain. Lung physiological parameters were recorded. Perfusate, bronchoalveolar lavage (BAL), and tissue samples were collected. All lungs in IGL-2M group completed 7 h EVLP protocol. Compared to OCS , IGL-2M reduced edema formation (p < 0.01), preserved superior compliance (p < 0.01), and maintained lower pulmonary vascular resistance (p < 0.01). IGL-2M showed lower perfusate concentrations of IL-1β (p < 0.05), IL-6 (p < 0.05), and TNF-α (p = 0.08). In BAL, IGL-2M reduced IL-1β (p < 0.01), IL-6 (p < 0.05), TNF-α (p < 0.01), and CXCL1 (p < 0.01). IGL-2M showed lower release of Syndecan-1 (p < 0.05). Compared to Perfadex Plus , IGL-2M was not inferior, with reduced expression of TNF-α in the perfusate (p < 0.05). IGL-2M effectively prevents edema development like Perfadex Plus . IGL-2M results in decreased inflammation and a stronger endothelial lining, making it a promising solution for lung preservation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Organ Preservation SolutionsReperfusion InjuryLungOrgan PreservationAnimalsRatsMalePolyethylene GlycolsLung TransplantationPerfusionRats, Sprague-DawleyCold IschemiaCitrates

Stichwörter der Autor:innen

endothelial glycocalyxischemia-reperfusion injurylung preservationpolyethylene glycol (PEG)preservation solution

Substanzen

Organ Preservation SolutionsPolyethylene GlycolsPerfadexCitrates

Autor:innen und Institutionen

  • Laboratory for Respiratory Diseases and Thoracic Surgery, Katholieke Universiteit Leuven, Leuven, Belgium.
  • Department of Thoracic Surgery, University Hospitals Leuven, Leuven, Belgium.
  • Centrum voor Moleculaire en Vasculaire Biologie, Katholieke Universiteit Leuven, Leuven, Belgium.
  • Laboratory of Molecular Virology and Gene Therapy, Katholieke Universiteit Leuven, Leuven, Belgium.
  • Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, Molecular, Structural and Translational Virology Research Group, Katholieke Universiteit Leuven, Leuven, Belgium.
  • Laboratory of Abdominal Transplantation, Transplantation Research Group, Department of Microbiology, Immunology and Transplantation, Katholieke Universiteit Leuven, Leuven, Belgium.

Zitieren

APA

Barbarossa, A., Van Slambrouck, J., Trivett, C., Kortleven, P., Vanluyten, C., Medina, A. M., Jin, X., Jannis, N., Özsoy, B., Claes, S., Schols, D., Wylin, T., Moermans, K., Stegen, S., Rosello, A. P., Inci, I., De Leyn, P., Vanaudenaerde, B., Pirenne, J., …, & Ceulemans, L. J. (2026). Institut Georges Lopez-2M as a Novel Lung Preservation Solution Attenuates Ischemia-Reperfusion Injury in a Rat Ex Vivo Lung Perfusion Model. Transplant International. https://doi.org/10.3389/ti.2026.15993

Vancouver

Barbarossa A, Van Slambrouck J, Trivett C, Kortleven P, Vanluyten C, Medina AM, et al. Institut Georges Lopez-2M as a Novel Lung Preservation Solution Attenuates Ischemia-Reperfusion Injury in a Rat Ex Vivo Lung Perfusion Model. Transplant International. 2026. doi:10.3389/ti.2026.15993

BibTeX
@article{Barbarossa2026,
  author = {Barbarossa, Annalisa and Van Slambrouck, Jan and Trivett, Cara and Kortleven, Phéline and Vanluyten, Cedric and Medina, Alberto Martin and Jin, Xin and Jannis, Nicole and Özsoy, Balin and Claes, Sandra and Schols, Dominique and Wylin, Tine and Moermans, Karen and Stegen, Steve and Rosello, Arnau Panisello and Inci, Ilhan and De Leyn, Paul and Vanaudenaerde, Bart and Pirenne, Jacques and Jones, Elizabeth A V and Ceulemans, Laurens J},
  title = {Institut Georges Lopez-2M as a Novel Lung Preservation Solution Attenuates Ischemia-Reperfusion Injury in a Rat Ex Vivo Lung Perfusion Model},
  journal = {Transplant International},
  year = {2026},
  doi = {10.3389/ti.2026.15993}
}
Kostenlos starten →